Search Within

Michael Morris

Formats
  1. Meeting Abstract (276)
  2. Journal Article (268)
  3. Review (21)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (588)
  2. Genitourinary Oncology Service (588)
  3. Solid Tumor Oncology Division (588)
  4. Radiology, Department of (165)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (142)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (29)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (45)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (45)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (588)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ra-223 experience in pretreated patients: EAP setting
    Meeting Abstract

    Sartor, A. O.; Fernandez, D. C.; Morris, M. J.; Iagaru, A.; Brown, A.; Almeida, F.; Sweeney, C.; Smith, M. R.; Dicker, A.; Wong, Y. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy
    Meeting Abstract

    Morris, M. J.; Hilden, P.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Dayan, E. S.; Filipenko, J.; Acosta, I.; Heller, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effects of radium-223 dichloride (Ra-223) with docetaxel (D) vs D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial
    Meeting Abstract

    Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Loriot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Curtis, K. R.; Taylor, B. S.; Arcila, M. E.; Brennan, R.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Radium-223 dichloride (Ra-223) in US expanded access program (EAP)
    Meeting Abstract

    Vogelzang, N. J.; Fernandez, D. C.; Morris, M. J.; Iagaru, A.; Brown, A.; Almeida, F.; Sweeney, C.; Smith, M. R.; Dicker, A.; Wong, Y. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prior and concurrent use of abiraterone and enzalutamide with Ra-223 in an expanded access setting
    Meeting Abstract

    Sartor, A. O.; Fernandez, D. C.; Morris, M. J.; Iagaru, A.; Brown, A.; Almeida, F.; Sweeney, C.; Smith, M. R.; Dicker, A.; Wong, Y. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of radium-223 dichloride (Ra-223) on pain from US EAP
    Meeting Abstract

    Morris, M. J.; Sartor, A. O.; Vogelzang, N. J.; Shore, N. D.; Cislo, P.; Bangerter, K.; Sweeney, C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pathologic correlation of (89)Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer
    Meeting Abstract

    Morris, M. J.; Solomon, S. B.; Durack, J. C.; O'Donoghue, J. A.; Lyashchenko, S. K.; Ruan, S. T.; Carrasquillo, J. A.; Lewis, J. S.; Martinez, D. F.; Parada, N. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save